• Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma Media
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
Skip to content
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
BioPharma Media

BioPharma Media

Biopharmaceutical industry analysis.
 Credible, reliable, equitable.

  • Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma Media
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy

Takeda Pharmaceutical

helicobacter-pylori
Posted inInfections, Regulatory

Voquezna: New Drug for Acid-Related Gastrointestinal Diseases

May 2, 2022September 8, 2022

Vonoprazan for Helicobacter pylori eradication and for treating erosive esophagitis, non-erosive gastroesophageal reflux disease (NERD), and gastroesophageal reflux disease (GERD).

cytomegalovirus
Posted inInfections, New Drugs, Regulatory

Livtencity: New Drug Against Post-Transplant Cytomegalovirus Infection

December 4, 2021September 8, 2022

Maribavir will suppress cytomegalovirus when ganciclovir, valganciclovir, cidofovir, or foscarnet do not work.

GammaDelta Therapeutics.
Posted inMergers & Acquisitions, Oncology

Takeda Bets on Promising Gamma Delta T-cell Immunotherapy

October 28, 2021September 8, 2022

UK-based GammaDelta Therapeutics has developed a pipeline of novel allogeneic cell therapies.

Zeposia: New Drug for Ulcerative Colitis
Posted inAutoimmune Diseases, New Drugs, Regulatory

Zeposia: New Drug for Ulcerative Colitis

June 2, 2021September 8, 2022

Oral ozanimod will provide clinical remission of ulcerative colitis for a third of patients.

Halozyme: Elegant Transformation of Drugs From Intravenous to Subcutaneous
Posted inPharma & Biotech

Halozyme: Elegant Transformation of Drugs From Intravenous to Subcutaneous

April 14, 2021September 8, 2022

Easy and quick administration of biological drugs. All for the convenience of patient care.

Febuxostat in Treatment of Gout: Walk With Death
Posted inDrug Safety, Metabolism, Regulatory

Febuxostat in Treatment of Gout: Walk With Death

April 7, 2021September 8, 2022

A popular antigout drug Uloric carries increased risks of death.

Pills.
Posted inOncology, Research

Not All Cancer Drugs Are Equally Useful

April 3, 2021September 8, 2022

Cheating out of ignorance, or Sleight of hand and no fraud. How pharmaceutical companies scam clinical trials.

BioPharma Media Logo
Biopharmaceutical industry analysis.
© 2023 BioPharma Media. Newspack by Automattic. The end-to-end solution. Privacy Policy
  • Facebook
  • Twitter
  • LinkedIn
  • Google News